Ostex and Metrika collaborating on OTC osteoporosis test development.
This article was originally published in The Tan Sheet
Executive Summary
OSTEX, METRIKA COLLABORATING ON OTC OSTEOPOROSIS TEST development. The two firms are working on a one-step disposable test based on Ostex' technology for detecting cross-linked N-Terminal Telopeptides (NTx), a specific degradation marker of type I bone collagen. A quantitative reading of bone resorption (loss) is made by measuring the level of NTx in a urine sample. An above-normal reading of bone resorption is associated with osteoporosis.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning